iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN – Get Free Report) shares were down 2.7% during trading on Friday . The company traded as low as $34.79 and last traded at $34.79. Approximately 314 shares were traded during mid-day trading, a decline of 83% from the average daily volume of 1,827 shares. The stock had previously closed at $35.77.
iShares Neuroscience and Healthcare ETF Stock Performance
The stock has a market capitalization of $5.22 million, a P/E ratio of 15.61 and a beta of 0.77. The stock has a 50-day simple moving average of $33.44 and a 200 day simple moving average of $32.21.
About iShares Neuroscience and Healthcare ETF
The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.
Further Reading
- Five stocks we like better than iShares Neuroscience and Healthcare ETF
- Samsung Joins the $1 Trillion Club as AI Memory Demand Explodes
- Japan’s Stealth Bull Market: How U.S. Investors Can Get Exposure
- 3 Stocks to Own If Gas Prices Keep Rising
- 3 Crucial Aerospace Component Makers That Analysts Love
Receive News & Ratings for iShares Neuroscience and Healthcare ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Neuroscience and Healthcare ETF and related companies with MarketBeat.com's FREE daily email newsletter.
